Opinion

DDW Editor Reece Armstrong speaks to Stephanie Seremetis, Chief Medical Officer, Rare Blood Disorders at Novo Nordisk to get her response to the company’s latest study results for its Mim8 antibody. Earlier this year, pharmaceutical company Novo Nordisk announced positive results from Phase I & II clinical trials investigating its antibody treatment for haemophilia A.   […]

CDMO in peptides and oligonucleotides manufacturing, Bachem, has started building a new future for oligonucleotides: solving the industry’s main challenges around capacity, sustainability and cost-effectiveness. Emerging as a new treatment option in rare and orphan disease areas, oligonucleotide therapeutics have matured into a drug class with a broad indication spectrum. The promise of oligonucleotides making […]

DDW’s Reece Armstrong speaks to Scott Gray, President & CEO of Clincierge about its unique approach to improving the clinical trial experience for patients.   For patients participating in a clinical trial, the experience can be one of considerable hardship, both from a perspective on their health and the impact on their everyday lives. Logistically demanding […]

Crystallisation is one of the oldest separation methods and has contributed to the efficient production of high-value products. However, to minimise contamination and maintain precision, control and quality, scientists will often spend up to 20% of their time cleaning equipment before testing. Here Thomas Kendall, application specialist at crystallisation and solid-state specialist Technobis Crystallization Systems, […]

For oligonucleotide API manufacturers, putting in place capacity and sustainability solutions will be essential in the future to meet increased demand for oligonucleotides. These molecules will be needed in ever greater quantities to fulfil the rising need for oligonucleotides as new uses for them are found in research, diagnosis and drug development. Seamus White is […]

Philip Gribbon is Head of Discovery Research at the Fraunhofer Institute for Translational Medicine and Pharmacology in Hamburg, Germany. Ahead of his participation in a Data Sharing panel at SLAS Europe 2022, Gribbon tells Megan Thomas about the importance and lasting impact of good quality data. Health and data science The Fraunhofer Society is the […]

The LSX World Congress returned for an in-person event in May, bringing together executives from the biotech, medtech and healthtech sectors, across two days to examine the latest trends across life sciences.  DDW’s Reece Armstrong attended the event – here are the key takeaways from the show.  One of the key theme’s across LSX was […]

As Chief Technical Lead and a Head of R&D at Samsung Biologics America, Soojin Han examines the challenges, tactics, and best partnering practices in cell line development (CLD). She emphasises the need to ensure a balance between shortening commercial CLD timelines, increasing efficiencies and maintaining product quality. Advances in treatments for oncological, autoimmune, and infectious […]

Listen to this article on the DDW Podcast: FRAME (Fund for the Replacement of Animals in Medical Experiments) Education and Outreach Manager Amy Beale discusses how current legislative and regulatory requirements for animal research could be strengthened to help prevent animal experiments and accelerate change. She also considers the factors influencing the lack of change within […]